Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe UK CHF

medmix AG (MEDXZ.XC)

10.10
+0.10
+(1.00%)
As of 9:48:48 AM GMT+1. Market Open.
Loading Chart for MEDXZ.XC
  • Previous Close 10.00
  • Open 10.20
  • Bid 10.08 x --
  • Ask 10.14 x --
  • Day's Range 10.05 - 10.34
  • 52 Week Range 8.10 - 17.34
  • Volume 5,278
  • Avg. Volume 6,365
  • Market Cap (intraday) 411.987M
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) --
  • EPS (TTM) -0.18
  • Earnings Date Feb 26, 2025
  • Forward Dividend & Yield 0.50 (5.00%)
  • Ex-Dividend Date Apr 25, 2025
  • 1y Target Est --

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company offers dental products, including mixing tips and cartridges for various applications, such as prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and general industrial industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. medmix AG was founded in 1922 and is based in Baar, Switzerland.

www.medmix.swiss

2,684

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MEDXZ.XC

View More

Performance Overview: MEDXZ.XC

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

MEDXZ.XC
14.51%
MSCI WORLD (^990100-USD-STRD)
5.85%

1-Year Return

MEDXZ.XC
32.06%
MSCI WORLD (^990100-USD-STRD)
6.68%

3-Year Return

MEDXZ.XC
67.46%
MSCI WORLD (^990100-USD-STRD)
21.47%

5-Year Return

MEDXZ.XC
75.57%
MSCI WORLD (^990100-USD-STRD)
77.89%

Compare To: MEDXZ.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEDXZ.XC

View More

Valuation Measures

Annual
As of 4/22/2025
  • Market Cap

    407.09M

  • Enterprise Value

    634.29M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.86

  • Price/Book (mrq)

    0.93

  • Enterprise Value/Revenue

    1.31

  • Enterprise Value/EBITDA

    9.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.53%

  • Return on Assets (ttm)

    1.22%

  • Return on Equity (ttm)

    -1.39%

  • Revenue (ttm)

    483.9M

  • Net Income Avi to Common (ttm)

    -7.4M

  • Diluted EPS (ttm)

    -0.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    118.1M

  • Total Debt/Equity (mrq)

    73.70%

  • Levered Free Cash Flow (ttm)

    58.44M

Research Analysis: MEDXZ.XC

View More

Company Insights: MEDXZ.XC

Research Reports: MEDXZ.XC

View More